| 國立臺灣大學 |
2014 |
Tumor detection in automated breast ultrasound images using quantitative tissue clustering
|
Moon, Woo Kyung; Lo, Chung-Ming; Chen, Rong-Tai; Shen, Yi-Wei; Chang, Jung Min; Huang, Chiun-Sheng; Chen, Jeon-Hor; Hsu, Wei-Wen; Chang, Ruey-Feng; 黃俊升 |
| 臺大學術典藏 |
2020-05-04T08:03:26Z |
Tumor detection in automated breast ultrasound using 3-D CNN and prioritized candidate aggregation
|
RUEY-FENG CHANG; Chang, R.-F.; Chen, R.-T.; Huang, C.-S.; Huang, Y.-S.; Chiang, T.-C.; Chiang, T.-C.;Huang, Y.-S.;Chen, R.-T.;Huang, C.-S.;Chang, R.-F. |
| 臺大學術典藏 |
2020-03-23T07:18:48Z |
Tumor detection in automated breast ultrasound using 3-D CNN and prioritized candidate aggregation
|
Chiang T.-C.; Huang Y.-S.; Chen R.-T.; CHIUN-SHENG HUANG; Chang R.-F. |
| 國立政治大學 |
2013-08 |
Tumor Detection in Automated Breast Ultrasound using Computer-aided Classification
|
羅崇銘; Lo*, Chung-Ming; Chang, Ruey-Feng; Huang, Chiun-Sheng; Moon, Woo Kyung; Shen, Yi-Wei; Hsu, Wei-Wen |
| 國立政治大學 |
2014-06 |
Tumor Detection in Automated Whole Breast Ultrasound using Topographic Watershed
|
羅崇銘; Lo, Chung-Ming; Chang*, Ruey-Feng; Chen, Rong-Tai; Huang, Chiun-Sheng; Yang, Ya- Wen; Chang, Yeun-Chung |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
Tumor detection strategy using ZnO light-emitting nanoprobes
|
Shen, Y.-C.; Lu, T.-C.; Yang, T.-L.; Huang, J.-J.; JIAN-JANG HUANG; TSUNG-LIN YANG; Yang, S.-C.; Yang, S.-C.;Shen, Y.-C.;Lu, T.-C.;Yang, T.-L.;Huang, J.-J. |
| 臺大學術典藏 |
2021-10-21T23:28:07Z |
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
|
Sheu, Zai Lin; Huang, Chi Ping; Chang, Chao Hsiang; CHUNG-HSIN CHEN; JIAN-HUA HONG; Weng, Han Yu; Tai, Ta Yao; Chung, Shiu Dong; Lo, Chi Wen; Hsueh, Thomas Y.; Tsai, Yao Chou; Jiang, Yuan Hong; Chiang, Bing Juin; Chen, Yung Tai; Lin, Jen Tai; Lin, Wei Yu; Jou, Yeong Chin; Tseng, Jen Shu; Wu, Chia Chang; Wu, Wen Jeng; Yeh, Hsin Chih |
| 臺大學術典藏 |
2021-10-25T02:40:32Z |
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
|
Sheu, Zai-Lin; Huang, Chi-Ping; Chang, Chao-Hsiang; CHUNG-HSIN CHEN; Hong, Jian-Hua; Weng, Han-Yu; Tai, Ta-Yao; Chung, Shiu-Dong; Lo, Chi-Wen; Hsueh, Thomas Y; Tsai, Yao-Chou; Jiang, Yuan-Hong; Chiang, Bing-Juin; Chen, Yung-Tai; Lin, Jen-Tai; Lin, Wei-Yu; Jou, Yeong-Chin; Tseng, Jen-Shu; Wu, Chia-Chang; Wu, Wen-Jeng; Yeh, Hsin-Chih |
| 臺大學術典藏 |
2021-10-26T02:57:34Z |
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
|
Sheu, Zai-Lin; Huang, Chi-Ping; Chang, Chao-Hsiang; Chen, Chung-Hsin; JIAN-HUA HONG; Weng, Han-Yu; Tai, Ta-Yao; Chung, Shiu-Dong; Lo, Chi-Wen; Hsueh, Thomas Y; Tsai, Yao-Chou; Jiang, Yuan-Hong; Chiang, Bing-Juin; Chen, Yung-Tai; Lin, Jen-Tai; Lin, Wei-Yu; Jou, Yeong-Chin; Tseng, Jen-Shu; Wu, Chia-Chang; Wu, Wen-Jeng; Yeh, Hsin-Chih |
| 國立成功大學 |
2021 |
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
|
Sheu, Z.-L.;Huang, C.-P.;Chang, Chang C.-H.;Chen, Chen C.-H.;Hong, J.-H.;Weng, H.-Y.;Tai, Tai T.-Y.;Chung, S.-D.;Lo, C.-W.;Hsueh, T.Y.;Tsai, Y.-C.;Jiang, Y.-H.;Chiang, B.-J.;Chen, Y.-T.;Lin, J.-T.;Lin, W.-Y.;Jou, Y.-C.;Tseng, J.-S.;Wu, C.-C.;Wu, Wu W.-J.;Yeh, H.-C. |
| 臺大學術典藏 |
2020-06-22T07:36:56Z |
Tumor Endothelial Marker 1 (TEM1/Endosialin/CD248) Enhances Wound Healing by Interacting with Platelet-Derived Growth Factor Receptors
|
Hong Y.-K.;Lee Y.-C.;Cheng T.-L.;Lai C.-H.;Hsu C.-K.;Kuo C.-H.;Hsu Y.-Y.;Li J.-T.;Chang B.-I.;Ma C.-Y.;Shu-Wha Lin;Wang K.-C.;Shi G.-Y.;Wu H.-L.; Hong Y.-K.; Lee Y.-C.; Cheng T.-L.; Lai C.-H.; Hsu C.-K.; Kuo C.-H.; Hsu Y.-Y.; Li J.-T.; Chang B.-I.; Ma C.-Y.; SHU-WHA LIN; Wang K.-C.; Shi G.-Y.; Wu H.-L. |
| 國立成功大學 |
2019-10 |
Tumor Endothelial Marker 1 (TEM1/Endosialin/CD248) Enhances Wound Healing by Interacting with Platelet-Derived Growth Factor Receptors
|
Hong;Yi-Kai;Lee;Yao-Chou;Cheng;Tsung-Lin;Lai;Chao-Han;Hsu;Chao-Kai;Kuo;Cheng-Hsiang;Hsu;Yun-Yan;Li;Jui-Ting;Chang;Bi-Ing;Ma;Chih-Yuan;Lin;Shu-Wha;Wang;Kuan-Chieh;Shi;Guey-Yueh;Wu;Hua-Lin |
| 國立成功大學 |
2022-06-22 |
Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling
|
Chen;Po-Sheng;Feng;Wen-Han;Tsai;Tzu-Hsien;Hong;Yi-Kai;Lee;An-Sheng;Chang;Kuan-Cheng;Chung;Hsing-Chun;Liu;Yen-Wen;Hsieh;Chih-Cheng;Fang;Yi-Hsian;Yang;Pei-Jung;Luo;Chawn-Yau;Liu;Ping-Yen;Cheng;Tsung-Lin;Li;Yi-Heng |
| 國立勤益科技大學 |
2009-12 |
Tumor Feature Reserved Compression Systems for Mammograms
|
林基源 |
| 國立勤益科技大學 |
2009-12 |
Tumor Feature Reserved Compression Systems for Mammograms
|
楊勝智 |
| 臺大學術典藏 |
2016 |
Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges
|
Lu L.-C.; Hsu C.-H.; CHIUN HSU; Cheng A.-L. |
| 國立臺灣大學 |
2016 |
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
|
Lu, Li-Chun; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges
|
Lu L.-C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-15T07:44:46Z |
Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges
|
LI-CHUN LU; Hsu C.-H.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:29:44Z |
Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges
|
Lu L.-C.; Hsu C.-H.; Hsu C.; ANN-LII CHENG |
| 國立成功大學 |
2017 |
Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma
|
Chan, S.-C.;Chang, K.-P.;Fang, Y.-H.D.;Tsang, N.-M.;Ng, S.-H.;Hsu, C.-L.;Liao, C.-T.;Yen, T.-C. |
| 中國醫藥大學 |
2010-06 |
Tumor heterogeneity of Figo stage III carcinoma of the uterine cervix:In regard to Kim et al.
|
陳尚文(Shang-Wen Chen)*; 梁基安(Ji-An Liang) |
| 亞洲大學 |
2017-03 |
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression
|
Hsieh, 林佑融；Yu-Jung Lin；Woei-Cherng；Woei-Cherng Shyu；Chi-Wei Chan；Chi-Wei Chang；Chi-Chung Wa；Chi-Chung Wang；Chung-Pu Wu；Chung-Pu Wu；Hsu-Tung Lee；Hsu-Tung Lee；Liang-Jwu Ch；Liang-Jwu Chen；謝佳宏；Chia-Hung |
| 國立臺灣大學 |
1999 |
Tumor Immunology - When a Cancer Cell Meets the Immune Cells
|
許世明; HSU, SU-MING |
| 臺大學術典藏 |
2018-09-10T07:47:37Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Sheu, B.-C. and Hsu, S.-M. and Ho, H.-N. and Lin, R.-H. and Huang, S.-C.; BOR-CHING SHEU |
| 臺大學術典藏 |
2018-09-10T07:48:02Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Sheu, B.-C. and Hsu, S.-M. and Ho, H.-N. and Lin, R.-H. and Huang, S.-C.; HONG-NERNG HO |
| 臺大學術典藏 |
2020-01-22T06:00:39Z |
Tumor immunology - When a cancer cell meets the immune cells
|
Bor-Ching Sheu;Hsu S.-M.;Ho H.-N.;Lin R.-H.;Huang S.-C.; BOR-CHING SHEU; Hsu S.-M.; Ho H.-N.; Lin R.-H.; Huang S.-C. |
| 臺大學術典藏 |
1999 |
Tumor immunology - When a cancer cell meets the immune cells
|
Huang S.-C.; Lin R.-H; HONG-NERNG HO; Hsu S.-M; Sheu B.-C; Sheu B.-C;Hsu S.-M;Hong-Nerng Ho;Lin R.-H;Huang S.-C. |
| 國立臺灣大學 |
2016 |
TUMOR INDUCED OSTEOMALACIA IN TAIWAN
|
Tsai, K. -S.; Lee, J. -C.; Shih, S. -R.; Chili, W. -Y.; Shih, S. R.; 蔡克嵩; 李仁傑; 施翔蓉 |
| 臺北醫學大學 |
1969-06 |
Tumor Inhibitions XLII Thalidasine A Novel Bisenzylisoquinoline Alkaloid Tumor Inhibitor from Thalictru dasycarpum
|
楊藏雄 |
| 臺北醫學大學 |
1969 |
Tumor Inhibitors. XLII. Thalidasine, a Novel Bisbenzylisoquinoline Alkaloid Tumor Inhibitor from Thalictrum dasycarpum
|
S. MORRIS KUPCHAN; T. H. YANG; GEORGE S. VASILIKIOTIS; MICHAEL H. BARNES; M. L. KING |
| 國家衛生研究院 |
2001-03-15 |
Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac
|
Chen, WS; Wei, SJ; Liu, JM; Hsiao, M; Lin, JK; Yang, WK |
| 國立臺灣大學 |
1988 |
Tumor Invasiveness and Prognosis in Resected Hepatocellular Carcinoma:Clinical and Pathogenetic Implications
|
許輝吉; Wu, T. T.; Wu, M. Z.; Sheu, J. C.; Lee, C. S.; Chen, D. S.; Hsieh, F. J.; Hsu, Hwei-Chi; Wu, T. T.; Wu, M. Z.; Sheu, J. C.; Lee, C. S.; Chen, D. S.; Hsieh, F. J. |
| 國立成功大學 |
2011-11 |
Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation
|
Chang, W-L |
| 臺大學術典藏 |
2021-01-26T03:36:41Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
Chung-Hsin Chen;Chen Y.-C.;Pu Y.-S.; CHUNG-HSIN CHEN; Chen Y.-C.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:45:56Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
Chen C.-H.;Chen Y.-C.;Yeong-Shiau Pu; Chen C.-H.; Chen Y.-C.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-03-02T14:00:17Z |
Tumor location on MRI determines outcomes of patients with prostate cancer after total prostate cryoablation
|
CHUNG-HSIN CHEN; Chen, Yu Ching; YEONG-SHIAU PU |
| 國立臺灣大學 |
2012 |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling; Liang, Po-Chin; Chen, Chien-Hung; 陳健弘; 梁博欽 |
| 臺大學術典藏 |
2018-09-10T09:15:18Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai, Wan-Ling;Liang, Po-Chin;Chen, Chien-Hung; Tsai, W.-L. and Liang, P.-C. and Chen, C.-H.; 陳健弘 ;梁博欽; Tsai, Wan-Ling; PO-CHIN LIANG; Liang, Po-Chin; Chen, Chien-Hung |
| 臺大學術典藏 |
2020-08-11T08:36:52Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; PO-CHIN LIANG; Chen C.-H. |
| 臺大學術典藏 |
2022-02-22T05:34:20Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:28Z |
Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma
|
Tsai W.-L.; Liang P.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-06-27T07:00:18Z |
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
|
Mok T.; Ladrera G.; Srimuninnimit V.; Sriuranpong V.; CHONG-JEN YU; Thongprasert S.; Sandoval-Tan J.; Lee J.S.; Fuerte F.; Shames D.S.; Klughammer B.; Truman M.; Perez-Moreno P.; Wu Y.-L. |
| 國立交通大學 |
2014-12-08T15:30:29Z |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Lin, Ming-Yu; Lu, Yen-Pei; Grumezescu, Alexandru Mihai; Ho, Fu Han; Kao, Ying-Hsien; Yang, Yuh-Shyong; Yang, Chih-Hui |
| 國立臺灣科技大學 |
2013 |
Tumor marker detection by aptamer-functionalized graphene oxide
|
Lin, M.-Y.;Lu, Y.-P.;Grumezescu, A.M.;Ho, F.H.;Kao, Y.-H.;Yang, Y.-S.;Yang, C.-H. |
| 義守大學 |
2013-01 |
Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide
|
Ming-Yu Lin;Yen-Pei Lu;Alexandru Mihai Grumezescu;Fu Han Ho;Ying-Hsien Kao;Yuh-Shyong Yang;Chih-Hui Yang |
| 高雄醫學大學 |
1997 |
Tumor markers in head and neck cancer
|
郭文烈 |
| 臺大學術典藏 |
2020-12-02T02:36:47Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
PAN-CHYR YANG; Luh K.T.; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 臺大學術典藏 |
2021-05-26T03:36:17Z |
Tumor markers of lung cancer: carcinoembryonic antigen and TuMark.
|
Yang P.C.; KWEN-TAY LUH; Lee Y.C.; Kuo S.H.; Huang T.W. |
| 國立臺灣大學 |
1989-09 |
Tumor Markers of Lung Cancer:Carcinoembryonic Antigen and Tumark
|
楊泮池; 郭壽雄; Luh, Kwen-Ttay; Yang, Pan-Chyr; Kuo, Sow-Hsong; Luh, Kwen-Ttay |
